A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Clinical trial NCT02819843 · COMPLETED
Trial details
- NCT number
- NCT02819843
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-21
- Primary completion
- 2024-02-22
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.